News
Gennova BioPharma Announces the Launch of HAMSYL Junior
Gennova Biopharmaceuticals Ltd., announces the launch of the India’s first paediatric pack size of pegaspargase – HAMSYL – Junior, which will now be available in a 1500 IU pack size. This marks a significant milestone in advancing healthcare for...
Drug Research
Berry’s Dual Chamber Inhaler Enables Access to Combination Drugs
Berry Global, a leader in the design, development, and production of patient-centred healthcare solutions, recently launched the BerryHaler, a dual chamber, dry powder inhaler (DPI) with a dose counter designed to provide better patient access to and support the...
News
Enhancing Power of Medicare Drug Price, Proposed By Biden
In a recent move, the US President Joe Biden happens to be taking on a bipartisan bogeyman prior to the crucial State of the Union speech, stressing the pharmaceutical industry as well as saying that he will work towards...
Drug Research
CordenPharma Expands Early Clinical Peptide Manufacturing to Launch IND-Targeted Peptide API to Injectable Drug Product Integrated Offer
After an initial expansion of the CordenPharma Frankfurt site for non-GMP manufacturing in 2020, and because of sustained success and exemplary performance delivered by their expert team, CordenPharma is pleased to announce the commissioning of new GMP capacities at...
News
New Treatment For Endometrial Cancer Gets Clearance From NHS
The NHS is all set to come up with groundbreaking immunotherapy that can go on to potentially offer a significant additional time when it comes to women who happen to be battling with advanced endometrial cancer.
As compared to standard...
News
Better Outcomes On Crohns Disease Treatment – UK Research
Top-down treatment by way of infliximab Plus, which is an immunomodulator, goes on to substantially enhance the outcomes for patients with newly diagnosed Crohn’s disease as compared to the accelerated step-up therapy, the UK research has found out.
It is...
News
Cresset Increases Its North America Presence with New Boston Site
Cresset, a provider of integrated in silico solutions for drug discovery has expanded its existing North American presence, with the creation of a new US facility in Boston, one of the world’s leading global hubs for pharma and life...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read